Gastric String Test Combined With a Rapid Antigen Assay for Helicobacter Pylori Detection
Key facts
- Who runs it
- Fu Jen Catholic University Hospital
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 40 people, planned
- Starts
- Dec 2026
- Expected to end
- Mar 2027
- Type of study
- Interventional
- Treatments tested
- HP String Test With Rapid Antigen Assay
- Record updated
- 4 November 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Adults aged 18-75 years
- Completed a 13C-urea breath test (UBT) within 28 days prior to enrollment, with documented test results
- Able to understand the study procedures and willing to provide written informed consent
Who cannot take part
- Use of antibiotics, bismuth-containing agents, or proton pump inhibitors (PPIs) within 4 weeks prior to enrollment, as these medications may affect H. pylori antigen detection
- History of dysphagia, esophageal stricture, or gastrointestinal obstruction
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This single-center, open-label, prospective pilot study aims to evaluate the feasibility, safety, and preliminary diagnostic performance of a minimally invasive gastric string sampling device combined with a rapid antigen assay for the detection of Helicobacter pylori infection.
Read full original descriptionShow less
A total of 40 participants with documented \^13C-urea breath test (UBT) results will be enrolled, including 30 UBT-positive and 10 UBT-negative participants. All participants will undergo gastric mucus collection using a disposable string sampling device, followed by H. pylori rapid antigen testing.
The primary objective is to assess the diagnostic sensitivity and specificity of the investigational test using \^13C-UBT as the reference standard. The secondary objective is to explore the correlation between the semi-quantitative test-line (T-line) color intensity of the rapid antigen assay and the corresponding UBT delta-over-baseline (DOB) values.
The group in the trial
- HP String Test With Rapid Antigen AssayTreatment being tested
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Pilot Study Evaluating a Novel Minimally Invasive String-test and Rapid Antigen Assay for Helicobacter Pylori Detection
- Criteria questions
- Built from NCT07906938, who can take part
- Record updated
- 4 November 2026